Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
carbonic anhydrase inhibitor |
| gptkbp:ATCCode |
S01EC03
|
| gptkbp:CASNumber |
554-57-4
|
| gptkbp:contraindication |
severe liver disease
sulfa allergy adrenal gland failure |
| gptkbp:eliminationHalfLife |
14 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:hasMolecularFormula |
C5H8N4O3S2
|
| https://www.w3.org/2000/01/rdf-schema#label |
methazolamide
|
| gptkbp:IUPACName |
N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:meltingPoint |
212°C
|
| gptkbp:metabolism |
hepatic
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:proteinBinding |
55%
|
| gptkbp:PubChem_CID |
4167
4023 DB00819 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
fatigue kidney stones taste alteration |
| gptkbp:synonym |
Neptazane
|
| gptkbp:UNII |
7P8N3D8K4Q
|
| gptkbp:usedFor |
altitude sickness
glaucoma |
| gptkbp:bfsParent |
gptkb:Carbonic_anhydrase_II
|
| gptkbp:bfsLayer |
7
|